Integra LifeSciences logo

Integra LifeSciences

IART | NASDAQ
Chart Builder DCF Calculator
$13.98
-$0.42 (-2.92%)
At close: Nov 16, 2026, 4:00 PM ET
$13.98
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET
-2.92%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
37.5
Fundamentals Weak
Market Sentiment Neutral
Moat Narrow
Sector Rank #595/1021 (Top 58%)

Key Statistics

Market Data

Market Cap $1.09B
1D Range
13.94 14.52
52W Range
8.90 19.85

Valuation (TTM)

PE 82.24
PB 1.02
EV/EBITDA 11.88

Valuation (NTM)

Forward PE 6.18
Forward PEG 14.14
Price Target $14.00
Loading financial charts...

Profile

Integra LifeSciences Holdings Corporation is a medical technology company focused on the creation, production, and global distribution of advanced surgical implants and instruments. These products are...

Sector Healthcare
Employees 4,427
IPO Date Aug 16, 1995
Fiscal Year January - December

Latest News

Integra LifeSciences Holdings Corporation (IART) Presents at 2026 UBS Global Healthcare Conference Transcript

7 days ago · seekingalpha.com

Integra LifeSciences Holdings Corporation (IART) Presents at 2026 UBS Global Healthcare Conference Transcript
Integra LifeSciences Holdings Corporation (IART) Q3 2026 Earnings Call Transcript

26 days ago · seekingalpha.com

Integra LifeSciences Holdings Corporation (IART) Q3 2026 Earnings Call Transcript
Integra: 3 Key Takeaways for Long-Term Investors

27 days ago · fool.com

Integra: 3 Key Takeaways for Long-Term Investors
What Integra LifeSciences (IART) Said on Its Q3 Earnings Call

27 days ago · marketbeat.com

What Integra LifeSciences (IART) Said on Its Q3 Earnings Call
Integra (IART) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

27 days ago · zacks.com

Integra (IART) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Integra LifeSciences (IART) Surpasses Q3 Earnings Estimates

27 days ago · zacks.com

Integra LifeSciences (IART) Surpasses Q3 Earnings Estimates
Integra LifeSciences Reports Third Quarter 2026 Financial Results

27 days ago · globenewswire.com

Integra LifeSciences Reports Third Quarter 2026 Financial Results
Integra Announces Completion of Refinancing Transactions

28 days ago · globenewswire.com

Integra Announces Completion of Refinancing Transactions
Integra LifeSciences to Highlight ENT and Instruments Portfolios and Sponsor New Clinical Research Presentations at AAO-HNSF 2026 Annual Meeting

1 month ago · globenewswire.com

Integra LifeSciences to Highlight ENT and Instruments Portfolios and Sponsor New Clinical Research Presentations at AAO-HNSF 2026 Annual Meeting
A Look at Integra Lifesciences Holdings Corp (IART) After 3.1% Gain -- GF Value $20.47 vs Price $13.41

1 month ago · gurufocus.com

A Look at Integra Lifesciences Holdings Corp (IART) After 3.1% Gain -- GF Value $20.47 vs Price $13.41

Earnings

Latest Earnings
Oct 21, 2026
EPS
$0.59
Beat +5.92%
REV
$411.18M
Miss -0.48%
Next Earnings
Feb 25, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
8
Consensus
Hold
Price Target
$14.00
Upside
+0.14%
Buy (1)
Hold (6)
Sell (1)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.